Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PFIZER INCPFE · Entity 2863 | Executive Vice President | August 01, 2018 | August 03, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PFIZER INC
Report date August 01, 2018 · Filed August 03, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,643 |
Ending reported balance
After 2018-08-01 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-08-01 · Sale · Disposed 5,400 · Balance 20,185 Row 2 · 2018-08-01 · Sale · Disposed 15,542 · Balance 4,643 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 01, 2018 Filed Aug 3, 2018 19:35 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 15,542 | $40.04 | $622,301.68 |
DisclosureSEC source: 0001225208-18-012254 · doc4.xml · nonDerivative · entry 2 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,643 Read SEC document |
| August 01, 2018 Filed Aug 3, 2018 19:35 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 5,400 | $40.05 | $216,270.00 |
DisclosureSEC source: 0001225208-18-012254 · doc4.xml · nonDerivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,185 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:44 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 19,273 | $0.00 Strike: $27.37 | $0.00 |
DisclosureSEC source: 0001225208-18-005102 · doc4.xml · derivative · entry 4 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,273 shares Expires 2018-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 11,699 | $35.70 | $417,654.30 |
DisclosureSEC source: 0001225208-18-005102 · doc4.xml · nonDerivative · entry 3 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,529 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:44 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 2,573 | $36.31 | $93,425.63 |
DisclosureSEC source: 0001225208-18-005102 · doc4.xml · nonDerivative · entry 2 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,228 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations and payment of exercise price in connection with the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 20:44 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 19,273 | $27.37 | $527,502.01 |
DisclosureSEC source: 0001225208-18-005102 · doc4.xml · nonDerivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 9,510 | $37.19 | $353,676.90 |
DisclosureSEC source: 0001225208-18-004459 · doc4.xml · nonDerivative · entry 5 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,770 Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 896 | $37.09 | $33,232.64 |
DisclosureSEC source: 0001225208-18-004459 · doc4.xml · nonDerivative · entry 4 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,280 F6 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:26 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,420 | $37.09 | $52,667.80 |
DisclosureSEC source: 0001225208-18-004703 · doc4.xml · nonDerivative · entry 2 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,528 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 26, 2018 Filed Feb 28, 2018 23:26 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 4,178 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-004703 · doc4.xml · nonDerivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,844 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 15,957 | $0.00 Strike: $18.90 | $0.00 |
DisclosureSEC source: 0001225208-18-004459 · doc4.xml · derivative · entry 6 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,957 shares Expires 2018-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 5,091 | $35.98 | $183,174.18 |
DisclosureSEC source: 0001225208-18-004459 · doc4.xml · nonDerivative · entry 3 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,176 F4 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F5 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,692 | $36.26 | $133,871.92 |
DisclosureSEC source: 0001225208-18-004459 · doc4.xml · nonDerivative · entry 2 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,267 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. F3 · price: Price is the closing price of Pfizer common stock on February 23, 2018 Read SEC document |
| February 24, 2018 Filed Feb 28, 2018 00:38 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 15,957 | $18.90 | $301,587.30 |
DisclosureSEC source: 0001225208-18-004459 · doc4.xml · nonDerivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:50 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 33,218 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003973 · doc4.xml · derivative · entry 2 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,218 Underlying: Common Stock · 33,218 shares Expires 2025-02-22 F2 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F2 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 22, 2018 Filed Feb 23, 2018 20:50 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 39,733 | $0.00 Strike: $35.74 | $0.00 |
DisclosureSEC source: 0001225208-18-003973 · doc4.xml · derivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,733 Underlying: Common Stock · 39,733 shares Expires 2023-02-22 F1 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F1 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,050 | $34.28 | $35,994.00 |
DisclosureSEC source: 0001225208-17-005107 · doc4.xml · nonDerivative · entry 3 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,730 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 989 | $34.28 | $33,902.92 |
DisclosureSEC source: 0001225208-17-005107 · doc4.xml · nonDerivative · entry 2 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,780 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 22:10 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 3,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-005107 · doc4.xml · nonDerivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,769 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:30 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 26,954 | $0.00 Strike: $34.06 | $0.00 |
DisclosureSEC source: 0001225208-17-004777 · doc4.xml · derivative · entry 6 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,954 Underlying: Common Stock · 26,954 shares Expires 2024-02-23 F6 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F6 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:30 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 32,468 | $0.00 Strike: $34.06 | $0.00 |
DisclosureSEC source: 0001225208-17-004777 · doc4.xml · derivative · entry 5 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,468 Underlying: Common Stock · 32,468 shares Expires 2022-02-23 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:30 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 21,238 | $0.00 Strike: $21.03 | $0.00 |
DisclosureSEC source: 0001225208-17-004777 · doc4.xml · derivative · entry 4 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,238 shares Expires 2017-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:30 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 10,282 | $32.49 | $334,062.18 |
DisclosureSEC source: 0001225208-17-004777 · doc4.xml · nonDerivative · entry 3 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,729 F3 · shares: The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon). F4 · price: Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:30 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 3,837 | $34.06 | $130,688.22 |
DisclosureSEC source: 0001225208-17-004777 · doc4.xml · nonDerivative · entry 2 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,011 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights. Read SEC document |
| February 23, 2017 Filed Feb 27, 2017 23:30 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 21,238 | $21.03 | $446,635.14 |
DisclosureSEC source: 0001225208-17-004777 · doc4.xml · nonDerivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,848 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 23:10 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 1,233 | $32.48 | $40,047.84 |
DisclosureSEC source: 0001225208-17-000508 · doc4.xml · nonDerivative · entry 1 LUND-JURGENSEN KIRSTEN · CIK 0001693493 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,523 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.